Results 1 to 10 of about 47,973 (163)

Real-Time Fibrinolysis Monitoring of Plasma Annular Clots [PDF]

open access: yesBiomolecules
Fibrinolysis assessment is critical for diagnosing and managing clinical blood disorders. Currently available viscoelastic testing platforms provide an overview of global coagulation and fibrinolysis profiles but lack fibrinolysis specific assessment of ...
Andres Prieto Trujillo   +3 more
doaj   +2 more sources

Is “Physiological Lysis” in Viscoelastometry a Plasmin-Mediated Process? [PDF]

open access: yesDiagnostics
Viscoelastic testing (VET) is widely used to guide hemostatic therapy in patients with coagulopathy. One important application is the detection of fibrinolysis, defined as a reduction in clot amplitude after maximum clot firmness (MCF), quantified as ...
Anikó Smudla   +4 more
doaj   +2 more sources

Assessment of Fibrinolysis in Sepsis Patients with Urokinase Modified Thromboelastography

open access: yesPLoS ONE, 2015
IntroductionImpairment of fibrinolysis during sepsis is associated with worse outcome. Early identification of this condition could be of interest. The aim of this study was to evaluate whether a modified point-of-care viscoelastic hemostatic assay can ...
Massimo Cressoni, Alessandro Protti
exaly   +2 more sources

An exploratory plasma-based functional assay for phenotypic characterization of fibrinolysis in dysfibrinogenemia [PDF]

open access: yesResearch and Practice in Thrombosis and Haemostasis
Background: Congenital dysfibrinogenemia exhibits heterogeneous clinical phenotypes, ranging from bleeding to thrombosis. However, conventional fibrinogen assays primarily evaluate clot formation alone.
Atsuo Suzuki   +7 more
doaj   +2 more sources

Outcomes according to timely or delayed primary percutaneous coronary intervention or fibrinolysis in a national registry of patients with ST-segment elevation myocardial infarction [PDF]

open access: yesOpen Heart
Background Time to reperfusion is a predictor of long-term outcomes in ST-segment elevation myocardial infarction (STEMI). Timely primary percutaneous coronary intervention (PCI) is the preferred strategy recommended by guidelines.
Peter Kearney   +14 more
doaj   +2 more sources

Neutrophil extracellular traps formation is associated with impaired clot retraction and fibrinolysis in asthma [PDF]

open access: yesFrontiers in Immunology
BackgroundAsthma is associated with an elevated risk of venous thromboembolism and pulmonary embolism; its etiology is not completely understood.ObjectiveThis study was designed to investigate whether the formation of neutrophil extracellular traps (NET)
Tomasz Misztal   +5 more
doaj   +2 more sources

Fibrinolysis vs. primary percutaneous coronary intervention for ST‐segment elevation myocardial infarction cardiogenic shock

open access: yesESC Heart Failure, 2021
Aims There are limited contemporary data on the use of initial fibrinolysis in ST‐segment elevation myocardial infarction cardiogenic shock (STEMI‐CS). This study sought to compare the outcomes of STEMI‐CS receiving initial fibrinolysis vs.
Saraschandra Vallabhajosyula   +14 more
doaj   +1 more source

Effect of acute alcohol intoxication on mortality, coagulation, and fibrinolysis in trauma patients.

open access: yesPLoS ONE, 2021
BackgroundThe effect of alcohol on the outcome and fibrinolysis phenotype in trauma patients remains unclear. Hence, we performed this study to determine whether alcohol is a risk factor for mortality and fibrinolysis shutdown in trauma patients ...
Il-Jae Wang   +11 more
doaj   +1 more source

Global coagulation assays to measure in vitro fibrinolysis

open access: yesThrombosis Update, 2021
(249/250 words): Introduction: Fibrinolysis is a critical component of hemostasis associated with poor outcomes if not treated early and effectively. Successful hemostasis management requires close fibrinolysis monitoring. The study aimed to compare the
Joao D. Dias   +3 more
doaj   +1 more source

Fibrinolytic therapy use for ST-segment elevation myocardial infarction and long-term outcomes in China: 2-year results from the China Acute Myocardial Infarction Registry

open access: yesBMC Cardiovascular Disorders, 2023
Background Data on fibrinolytic therapy use for ST-segment elevation myocardial infarction (STEMI) and long-term clinical outcomes in developing countries are limited.
Chao Wu   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy